Canadian researchers are reporting a potential advance in the treatment of Ebola virus infection, one of the most deadly pathogens known to humankind.
Researchers from the National Microbiology Laboratory in Winnipeg are reporting that monkeys deliberately infected with Ebola were successfully saved with a cocktail of antibodies against the virus.
Four of four monkeys given the treatment 24 hours after infection survived. And two of four monkeys treated 48 hours after infection also survived.
There currently is no vaccine and no treatment for Ebola, a viral hemorrhagic fever that causes sporadic, tragic outbreaks in countries in central Africa.
This treatment isn't ready for human use yet. And even if the work continues to look promising, hurdles will undoubtedly arise when attempts are made to translate findings in the lab to a usable therapy in the field.